 evalu oral dosag ondansetron prevent nausea emesi cyclophosphamide-doxorubicin chemotherapi antiemet efficaci safeti differ oral dose ondansetron GR novel serotonin receptor antagonist consecut seri breast cancer patient cyclophosphamide-doxorubicin-bas chemotherapi first time patient oral dose mg mg mg ondansetron time day first minut cyclophosphamid infus efficaci convent antiemet regimen intraven lorazepam metoclopramid chemotherapi mg prochlorperazin studi day time studi day fourth seri patient compar characterist number emet episod assess nausea appetit advers event studi period pretreat posttreat clinic laboratori data emesi studi period patient ondansetron dose patient convent therapi incid intens nausea dose ondansetron convent group ondansetron-rel side effect mild revers dose-depend manner effect headach stomach cramp diarrhea fatigu serum transaminas concentr patient mg dose ondansetron tremor muscl twitch oral ondansetron effect safe antiemet patient noncisplatin cyclophosphamide-doxorubicin-bas chemotherapi antiemet activ dose-rel